Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed, indicating an update to the history log's versioning metadata. This change does not alter study data or core content.
    Difference
    0.1%
    Check dated 2026-09-20T19:44:55.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The record history shows an update to recruitment status, indicating the trial is active but not currently enrolling participants. This signals that enrollment is not open at this time.
    Difference
    0.1%
    Check dated 2026-09-06T22:49:12.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.5 to v3.6.6, indicating a minor system update to the record history.
    Difference
    0.1%
    Check dated 2026-08-30T21:43:13.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.5) has been added to the history, indicating a recent update to the page. The previous revision (v3.6.4) is listed under deletions, suggesting it is no longer part of the current change set.
    Difference
    0.1%
    Check dated 2026-08-09T11:04:15.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaced v3.6.3 in the page history, indicating a new version of the record was published.
    Difference
    0.1%
    Check dated 2026-07-25T22:48:49.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    On 2026-07-13, a Study Status entry was added to the record history to reflect the current status of the trial. On 2026-07-10, a numeric value 28 was added in the history, and a prior deletion on 2026-04-07 removed an earlier item from the history.
    Difference
    0.3%
    Check dated 2026-07-18T19:36:15.000Z thumbnail image

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.